Cresset and Optibrium Announce Technology Collaboration

Technology exchange combines unique methods for design of novel, high quality compounds in drug discovery

06-Jan-2012 - United Kingdom

Cresset and Optibrium announced an agreement to collaborate on the development of next-generation platforms. The companies will work together, combining unique approaches to help drug discovery projects quickly identify novel, potent compounds with a high chance of success downstream.

The collaboration will involve a two-way exchange of technologies: Optibrium’s ADME models, currently provided as a plug-in module for its StarDrop™ software platform, will be made available to users of Cresset’s desktop applications. Similarly, Cresset’s FieldAlignTM software, which helps chemists understand the three-dimensional structure-activity-relationship of their chemistry in order to design active compounds, will be made available as an optional plug-in module for StarDrop, which helps project teams to confidently target compounds with a good balance of properties for their therapeutic objectives.
 

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances